Understanding obesity and endometrial cancer risk: Opportunities for prevention

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 6, 2011, Pages 518-525

  Schmandt, Rosemarie E ^a   Iglesias, David A ^a   Co, Ngai Na ^a   Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

endometrial cancer; estrogen; insulin; obesity; prevention

Indexed keywords

ADIPOCYTOKINE; ANDROGEN; ANTINEOPLASTIC AGENT; CHOLESTEROL; CYCLIN A; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTRONE; GLUCOSE; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; LEVONORGESTREL; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; RAF PROTEIN; RAS PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C RECEPTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

BEHAVIOR; BODY MASS; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DIET; ENDOCRINE DISEASE; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; EXERCISE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SIGNAL TRANSDUCTION;

DIABETES MELLITUS, TYPE 2; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; OBESITY; RISK FACTORS;

EID: 81855170040     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.05.042     Document Type: Review

References (83)

1. G.K. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer, and D. Bull Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study BMJ 335 2007 1134
2. L. Bessonova, S.F. Marshall, and A. Ziogas The association of body mass index with mortality in the California teachers study Int J Cancer 2011 Epub ahead of print
3. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 2008 569 578 (Pubitemid 351232031)
4. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638 (Pubitemid 36459468)
5. V.E. von Gruenigen, C. Tian, H. Frasure, S. Waggoner, H. Keys, and R.R. Barakat Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study Cancer 107 2006 2786 2791 (Pubitemid 44937031)
6. P.T. Soliman, R.L. Bassett Jr, and E.B. Wilson Limited public knowledge of obesity and endometrial cancer risk: what women know Obstet Gynecol 112 2008 835 842
7. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591 (Pubitemid 39025053)
8. W.C. Boon, J.D. Chow, and E.R. Simpson The multiple roles of estrogens and the enzyme aromatase Prog Brain Res 181 2010 209 232
9. R.C. van Kruijsdijk, E. van der Wall, and F.L. Visseren Obesity and cancer: the role of dysfunctional adipose tissue Cancer Epidemiol Biomarkers Prev 18 2009 2569 2578
10. J.A. Cauley, J.P. Gutai, L.H. Kuller, D. LeDonne, and J.G. Powell The epidemiology of serum sex hormones in postmenopausal women Am J Epidemiol 129 1989 1120 1131 (Pubitemid 19148455)
11. E.R. Simpson, and C.R. Mendelson Effect of aging and obesity on aromatase activity of human adipose cells Am J Clin Nutr 45 1987 290 295
12. J. Szymczak, A. Milewicz, J.H. Thijssen, M.A. Blankenstein, and J. Daroszewski Concentration of sex steroids in adipose tissue after menopause Steroids 63 1998 319 321 (Pubitemid 28265669)
13. J. Geisler Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators J Steroid Biochem Mol Biol 86 2003 245 253 (Pubitemid 37420000)
14. A.S. Morisset, K. Blouin, and A. Tchernof Impact of diet and adiposity on circulating levels of sex hormone-binding globulin and androgens Nutr Rev 66 2008 506 516
15. R. O'Lone, M.C. Frith, E.K. Karlsson, and U. Hansen Genomic targets of nuclear estrogen receptors Mol Endocrinol 18 2004 1859 1875 (Pubitemid 39022608)
16. M. Marino, P. Galluzzo, and P. Ascenzi Estrogen signaling multiple pathways to impact gene transcription Curr Genomics 7 2006 497 508 (Pubitemid 46068961)
17. M. Marino, P. Ascenzi, and F. Acconcia S-palmitoylation modulates estrogen receptor alpha localization and functions Steroids 71 2006 298 303
18. R. Kaaks, A. Lukanova, and M.S. Kurzer Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review Cancer Epidemiol Biomarkers Prev 11 2002 1531 1543 (Pubitemid 36020003)
19. A.E. Schindler Progestogen deficiency and endometrial cancer risk Maturitas 62 2009 334 337
20. S. Papaioannou, and J. Tzafettas Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer Best Pract Res Clin Obstet Gynaecol 24 2010 19 27
21. M.O. Goodarzi, D.A. Dumesic, G. Chazenbalk, and R. Azziz Polycystic ovary syndrome: etiology, pathogenesis and diagnosis Nat Rev Endocrinol 7 2011 219 231
22. J. Vrbikova, and V. Hainer Obesity and polycystic ovary syndrome Obes Facts 2 2009 26 35
23. E.J. Fearnley, L. Marquart, A.B. Spurdle, P. Weinstein, and P.M. Webb Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study Cancer Causes Control 21 2010 2303 2308
24. S.M. Shoff, and P.A. Newcomb Diabetes, body size, and risk of endometrial cancer Am J Epidemiol 148 1998 234 240 (Pubitemid 28355341)
25. E. Weiderpass, I. Persson, H.O. Adami, C. Magnusson, A. Lindgren, and J.A. Baron Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden) Cancer Causes Control 11 2000 185 192 (Pubitemid 30088399)
26. K.E. Anderson, E. Anderson, and P.J. Mink Diabetes and endometrial cancer in the Iowa women's health study Cancer Epidemiol Biomarkers Prev 10 2001 611 616 (Pubitemid 32705512)
27. E. Salazar-Martinez, E.C. Lazcano-Ponce, and G.G. Lira-Lira Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women Cancer Causes Control 11 2000 707 711
28. F. Parazzini, C. La Vecchia, and E. Negri Diabetes and endometrial cancer: an Italian case-control study Int J Cancer 81 1999 539 542 (Pubitemid 29203049)
29. E. Friberg, C.S. Mantzoros, and A. Wolk Diabetes and risk of endometrial cancer: a population-based prospective cohort study Cancer Epidemiol Biomarkers Prev 16 2007 276 280 (Pubitemid 46383346)
30. R. Troisi, N. Potischman, R.N. Hoover, P. Siiteri, and L.A. Brinton Insulin and endometrial cancer Am J Epidemiol 146 1997 476 482 (Pubitemid 27391408)
31. P.T. Soliman, D. Wu, and G. Tortolero-Luna Association between adiponectin, insulin resistance, and endometrial cancer Cancer 106 2006 2376 2381 (Pubitemid 43787661)
32. L. Dal Maso, L.S. Augustin, and A. Karalis Circulating adiponectin and endometrial cancer risk J Clin Endocrinol Metab 89 2004 1160 1163 (Pubitemid 38368405)
33. E. Petridou, C. Mantzoros, and N. Dessypris Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece J Clin Endocrinol Metab 88 2003 993 997 (Pubitemid 36337745)
34. A.E. Cust, R. Kaaks, and C. Friedenreich Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women J Clin Endocrinol Metab 92 2007 255 263 (Pubitemid 46067541)
35. Q. Zhang, Q. Shen, and J. Celestino Enhanced estrogen-induced proliferation in obese rat endometrium Am J Obstet Gynecol 200 2009 186.e1 186.e8
36. D.M. Klotz, S.C. Hewitt, and P. Ciana Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk J Biol Chem 277 2002 8531 8537 (Pubitemid 34968316)
37. S.C. Hewitt, Y. Li, L. Li, and K.S. Korach Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elements J Biol Chem 285 2010 2676 2685
38. E.M. Rutanen Insulin-like growth factors in endometrial function Gynecol Endocrinol 12 1998 399 406
39. E.M. Rutanen Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium: effect of intrauterine levonorgestrel delivery Hum Reprod 15 suppl 2000 173 181
40. A.E. Cust, N.E. Allen, and S. Rinaldi Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition Int J Cancer 120 2007 2656 2664 (Pubitemid 46651288)
41. A. Lukanova, A. Zeleniuch-Jacquotte, and E. Lundin Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer Int J Cancer 108 2004 262 268 (Pubitemid 37541781)
42. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
43. S.E. Shoelson, L. Herrero, and A. Naaz Obesity, inflammation, and insulin resistance Gastroenterology 132 2007 2169 2180 (Pubitemid 46693756)
44. I. Nieto-Vazquez, S. Fernandez-Veledo, D.K. Kramer, R. Vila-Bedmar, L. Garcia-Guerra, and M. Lorenzo Insulin resistance associated to obesity: the link TNF-alpha Arch Physiol Biochem 114 2008 183 194 (Pubitemid 352009305)
45. M. Shaarawy, and O. Abdel-Aziz Serum tumour necrosis factor alpha levels in benign and malignant lesions of the endometrium in postmenopausal women: a preliminary study Acta Oncol 31 1992 417 420
46. A. Cymbaluk, A. Chudecka-Glaz, and I. Rzepka-Gorska Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer Eur J Obstet Gynecol Reprod Biol 136 2008 74 77
47. M. Ferdeghini, A. Gadducci, and C. Prontera Serum interleukin-6 levels in uterine malignancies: preliminary data Anticancer Res 14 1994 735 737 (Pubitemid 24172201)
48. M. Hlavna, L. Kohut, and J. Lipkova Relationship of resistin levels with endometrial cancer risk Neoplasma 58 2011 124 128
49. Y.C. Long, and J.R. Zierath AMP-activated protein kinase signaling in metabolic regulation J Clin Invest 116 2006 1776 1783 (Pubitemid 44033297)
50. L. Dossus, S. Rinaldi, and S. Becker Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study Endocr Relat Cancer 17 2010 1007 1019
51. T. Wang, T.E. Rohan, and M.J. Gunter A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone non-users Cancer Epidemiol Biomarkers Prev 20 2011 971 977
52. W. Wen, Q. Cai, and Y.B. Xiang The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk Cancer 112 2008 2409 2416
53. D.W. Kaufman, S. Shapiro, and D. Slone Decreased risk of endometrial cancer among oral-contraceptive users N Engl J Med 303 1980 1045 1047 (Pubitemid 10025217)
54. V. Beral, P. Hannaford, and C. Kay Oral contraceptive use and malignancies of the genital tract: results from the Royal College of General Practitioners' Oral Contraception study Lancet 2 1988 1331 1335 (Pubitemid 19004435)
55. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development Combination oral contraceptive use and the risk of endometrial cancer JAMA 257 1987 796 800
56. L.M. Lopez, D.A. Grimes, M. Chen-Mok, C. Westhoff, A. Edelman, and F.M. Helmerhorst Hormonal contraceptives for contraception in overweight or obese women Cochrane Database Syst Rev 7 2010 CD008452
57. G.L. Maxwell, J.M. Schildkraut, and B. Calingaert Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk Gynecol Oncol 103 2006 535 540 (Pubitemid 44602164)
58. R.M. Beining, L.K. Dennis, E.M. Smith, and A. Dokras Meta-analysis of intrauterine device use and risk of endometrial cancer Ann Epidemiol 18 2008 492 499
59. D.T. Wheeler, R.E. Bristow, and R.J. Kurman Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins Am J Surg Pathol 31 2007 988 998 (Pubitemid 47012294)
60. A.V. Patel, H.S. Feigelson, and J.T. Talbot The role of bodyweight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women Int J Cancer 123 2008 1877 1882
61. C.L. Rock, S.W. Flatt, and C.A. Thomson Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer J Clin Oncol 22 2004 2379 2387 (Pubitemid 41115395)
62. T.J. Key, N.E. Allen, E.A. Spencer, and R.C. Travis Nutrition and breast cancer Breast 12 2003 412 416 (Pubitemid 38008652)
63. T.J. Key, P.N. Appleby, and G.K. Reeves Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women J Natl Cancer Inst 95 2003 1218 1226 (Pubitemid 37069552)
64. A. McTiernan, L. Wu, and C. Chen Relation of BMI and physical activity to sex hormones in postmenopausal women Obesity (Silver Spring) 14 2006 1662 1677 (Pubitemid 46214834)
65. C.M. Friedenreich, C.G. Woolcott, and A. McTiernan Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women J Clin Oncol 28 2010 1458 1466
66. A. McTiernan Mechanisms linking physical activity with cancer Nat Rev Cancer 8 2008 205 211 (Pubitemid 351301840)
67. A. McTiernan, M. Irwin, and V. Vongruenigen Weight, physical activity, diet, and prognosis in breast and gynecologic cancers J Clin Oncol 28 2010 4074 4080
68. S. Pendyala, L.M. Neff, M. Suarez-Farinas, and P.R. Holt Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis Am J Clin Nutr 93 2011 234 242
69. C. Doyle, L.H. Kushi, and T. Byers Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices CA Cancer J Clin 56 2006 323 353 (Pubitemid 44903908)
70. H. Ashrafian, K. Ahmed, and S.P. Rowland Metabolic surgery and cancer: protective effects of bariatric procedures Cancer 117 2011 1788 1799
71. L. Sjostrom, A. Gummesson, and C.D. Sjostrom Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects study): a prospective, controlled intervention trial Lancet Oncol 10 2009 653 662
72. T.D. Adams, A.M. Stroup, and R.E. Gress Cancer incidence and mortality after gastric bypass surgery Obesity (Silver Spring) 17 2009 796 802
73. G. Ungar, L. Freedman, and S.L. Shapiro Pharmacological studies of a new oral hypoglycemic drug Proc Soc Exp Biol Med 95 1957 190 192
74. G. Zhou, R. Myers, and Y. Li Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 2001 1167 1174 (Pubitemid 32995375)
75. M. Jalving, J.A. Gietema, and J.D. Lefrandt Metformin: taking away the candy for cancer? Eur J Cancer 46 2010 2369 2380
76. J.A. Engelman, and L.C. Cantley Chemoprevention meets glucose control Cancer Prev Res (Phila) 3 2010 1049 1052
77. I. Ben Sahra, Y. Le Marchand-Brustel, J.F. Tanti, and F. Bost Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9 2010 1092 1099
78. D. Li, S.C. Yeung, M.M. Hassan, M. Konopleva, and J.L. Abbruzzese Antidiabetic therapies affect risk of pancreatic cancer Gastroenterology 137 2009 482 488
79. S. Jiralerspong, S.L. Palla, and S.H. Giordano Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer J Clin Oncol 27 2009 3297 3302
80. J.L. Wright, and J.L. Stanford Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study Cancer Causes Control 20 2009 1617 1622
81. K.A. Brown, N.I. Hunger, M. Docanto, and E.R. Simpson Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase Breast Cancer Res Treat 123 2010 591 596
82. Y. Xie, Y.L. Wang, and L. Yu Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells J Steroid Biochem Mol Biol 126 2011 113 120
83. L.M. Berstein, M.P. Boyarkina, E.V. Tsyrlina, E.A. Turkevich, and V.F. Semiglazov More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin Med Oncol 2010 Epub ahead of print